je.st
news
Tag: pfizer
Pfizer Inc. (PFE) Shares Sold by Vigilant Capital Management LLC
2016-03-12 14:52:13| Biotech - Topix.net
Vigilant Capital Management LLC decreased its stake in Pfizer Inc. by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,374 shares of the biopharmaceutical company's stock after selling 2,000 shares during the period.
Tags: management
capital
llc
sold
FDA expands use of Pfizer drug for rare form of lung cancer
2016-03-11 21:25:28| Biotech - Topix.net
" The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation. The agency said Friday that Xalkori capsules are now approved for patients with the ROS-1 gene mutation, who make up about 1 percent of U.S. patients with non-small cell lung cancer, the most common form of the disease.
Pfizer Buys... Pfizer
2016-03-09 19:35:14| Industrial Machines - Topix.net
Pfizer entered into an accelerated share repurchase agreement with Goldman to repurchase $5 billion of Pfizer common stock. The $36.85 net arbitrage spread in its acquisition of Botox maker Allergan offers a 16% annual return if the deal closes by year-end.
Trustco Bank Corp N y Reduces Position in Pfizer Inc.
2016-03-08 10:36:20| Biotech - Topix.net
Trustco Bank Corp N Y cut its stake in shares of Pfizer Inc. by 0.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission . The fund owned 41,138 shares of the biopharmaceutical company's stock after selling 200 shares during the period.
Pfizer Announces FDA Approval Of XELJANZ XR (tofacitinib citrate) Extended-Release Tablets, The First And Only Once-Daily Oral JAK Inhibitor Treatment For Rheumatoid Arthritis
2016-03-02 04:30:55| drugdiscoveryonline Home Page
Pfizer Inc. announced recently that the U.S. Food and Drug Administration (FDA) has approved XELJANZ XR (tofacitinib citrate) extended-release 11 mg tablets for the once-daily treatment of moderate to severe rheumatoid arthritis (RA) in patients who have had an inadequate response or intolerance to methotrexate (MTX)
Tags: treatment
approval
oral
announces
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »